TESS Research Foundation Receives FDA Clearance to Launch First Human Clinical Trial for TSHA-105, a Gene Therapy for SLC13A5 Epilepsy!

Driving Research to Cure
SLC13A5 Epilepsy

Join the TESS Community: Subscribe for updates on the latest research, treatments, and news.

SIGN UP

We are Here for YOU

NEWLY
DIAGNOSED

PHYSICIAN
RESOURCES

RESEARCHER
TOOLKIT

GET
INVOLVED!

NEW!

Watch our video that features our superheroes’ smiling faces, the challenging obstacles they endure, and how hard they fight.

Learn More

Learn more about the Nye Family’s journey to diagnosis and the founding of TESS Research Foundation.

Biel’s Superhero Story
Callum’s Superhero Story
Dawood’s Superhero Story
Understanding Brain Excitability and Seizures in SLC13A5 Epilepsy

Science SimplifiedUnderstanding Brain Excitability and Seizures...

TESS Research Foundation Awarded Funding for a Project to Advance SLC13A5 Epilepsy Patient-Centered CER

NewsTESS Research Foundation Awarded Funding...

Science Summary: Understanding Development and Quality of Life in Individuals with SLC13A5 Epilepsy

Science SimplifiedScience Summary: Understanding Development...

We are committed to finding a cure for SLC13A5 Epilepsy.

You make it possible.

SLC13A5 Epilepsy, also known as SLC13A5 Deficiency or Citrate Transporter Disorder, is a newly discovered genetic cause of epilepsy. Through community support and your generosity, we are helping children affected by SLC13A5 Epilepsy through cutting-edge, patient-centered research, and by connecting families, doctors, and researchers to improve diagnosis and care – and ultimately find a cure.